Serum alpha-fetoprotein levels during and after interferon therapy and the development of hepatocellular carcinoma in patients with chronic hepatitis C.

Tamura, Yasushi; Yamagiwa, Satoshi; Aoki, Yohei; Kurita, So; Suda, Takeshi; Ohkoshi, Shogo; Nomoto, Minoru; Aoyagi, Yutaka

Tamura, Yasushi; Yamagiwa, Satoshi; Aoki, Yohei; Kurita, So; Suda, Takeshi; Ohkoshi, Shogo; Nomoto, Minoru; Aoyagi, Yutaka.

Affiliation

Tamura Y; Division of Gastroenterology and Hepatology, Graduate School of Medical and Dental Sciences, Niigata University, Niigata, Japan. ytamura@med.niigata-u.ac.jp

Dig Dis Sci ; 54(11): 2530-7, 2009 Nov.

Article in En | MEDLINE | ID: mdl-19093203

Subject(s)

Antiviral Agents/therapeutic use; Carcinoma, Hepatocellular/blood; Hepatitis C, Chronic/blood; Interferons/therapeutic use; Liver Neoplasms/blood; alpha-Fetoproteins/metabolism; Adult; Aged; Carcinoma, Hepatocellular/etiology; Female; Hepatitis C, Chronic/complications; Hepatitis C, Chronic/drug therapy; Humans; Liver Neoplasms/etiology; Male; Middle Aged; Retrospective Studies; Risk Factors

Fulltext

XML

PubMed Links

Search on Google

Full text: 1 Database: MEDLINE Main subject: Antiviral Agents / Alpha-Fetoproteins / Interferons / Carcinoma, Hepatocellular / Hepatitis C, Chronic / Liver Neoplasms Type of study: Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Adult / Aged / Female / Humans / Male / Middle aged Language: En Year: 2009 Type: Article

Fulltext

XML

PubMed Links

Search on Google